BeiGene
(NASDAQ:BGNE)
$156.39
1.31[0.84%]
At close: Mar 28
$156.39
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$431.00
Lowest Price Target1
$161.00
Consensus Price Target1
$283.07

BeiGene Stock (NASDAQ:BGNE), Analyst Ratings, Price Targets, Predictions

BeiGene Ltd has a consensus price target of $283.07, established from looking at the 40 latest analyst ratings. The last 3 analyst ratings were released from Bernstein, JP Morgan, and Guggenheim on March 27, 2024, March 19, 2024, and February 27, 2024. With an average price target of $230.67 between Bernstein, JP Morgan, and Guggenheim, there's an implied 47.49% upside for BeiGene Ltd from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
Feb
2
Mar
1
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Bernstein
JP Morgan
Guggenheim
Citigroup
B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for BeiGene

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/27/2024BGNEBuy Now
BeiGene
$156.392.95%Bernstein
Rebecca Liang
$196 → $161MaintainsMarket PerformGet Alert
03/19/2024BGNEBuy Now
BeiGene
$156.3918.93%JP Morgan
Jessica Fye
$184 → $186MaintainsOverweightGet Alert
02/27/2024BGNEBuy Now
BeiGene
$156.39120.6%Guggenheim
Michael Schmidt
$350 → $345MaintainsBuyGet Alert
02/06/2024BGNEBuy Now
BeiGene
$156.3918.29%JP Morgan
Jessica Fye
→ $185Assumes → OverweightGet Alert
10/26/2023BGNEBuy Now
BeiGene
$156.3982.24%Citigroup
Yigal Nochomovitz
$290 → $285MaintainsBuyGet Alert
09/21/2023BGNEBuy Now
BeiGene
$156.3985.43%Citigroup
Yigal Nochomovitz
$285 → $290MaintainsBuyGet Alert
09/20/2023BGNEBuy Now
BeiGene
$156.3935.56%B of A Securities
David Li
$224.13 → $212MaintainsNeutralGet Alert
09/12/2023BGNEBuy Now
BeiGene
$156.3965.61%Macquarie
Jake Lynch
→ $259Initiates → OutperformGet Alert
09/12/2023BGNEBuy Now
BeiGene
$156.3965.61%RBC Capital
Jake Lynch
→ $259Initiates → OutperformGet Alert
08/29/2023BGNEBuy Now
BeiGene
$156.39103.98%Morgan Stanley
Matthew Harrison
$321 → $319MaintainsOverweightGet Alert
08/17/2023BGNEBuy Now
BeiGene
$156.3983.52%Jefferies
Kelly Shi
→ $287Initiates → BuyGet Alert
08/07/2023BGNEBuy Now
BeiGene
$156.3991.83%JP Morgan
Xiling Chen
$297 → $300MaintainsOverweightGet Alert
07/17/2023BGNEBuy Now
BeiGene
$156.3975.84%Citigroup
Yigal Nochomovitz
→ $275Initiates → BuyGet Alert
06/30/2023BGNEBuy Now
BeiGene
$156.3925.33%Bernstein
Rebecca Liang
$335 → $196DowngradeOutperform → Market PerformGet Alert
04/12/2023BGNEBuy Now
BeiGene
$156.3968.36%B of A Securities
David Li
$230.1 → $263.3MaintainsNeutralGet Alert
02/28/2023BGNEBuy Now
BeiGene
$156.39123.8%Guggenheim
Michael Schmidt
→ $350Reiterates → BuyGet Alert
02/28/2023BGNEBuy Now
BeiGene
$156.3967.53%Cowen & Co.
Yaron Weber
$213 → $262MaintainsOutperformGet Alert
02/28/2023BGNEBuy Now
BeiGene
$156.39105.26%Morgan Stanley
Matthew Harrison
$325 → $321MaintainsOverweightGet Alert
01/24/2023BGNEBuy Now
BeiGene
$156.39107.81%Morgan Stanley
Matthew Harrison
$295 → $325MaintainsOverweightGet Alert

FAQ

Q

What is the target price for BeiGene (BGNE)?

A

The latest price target for BeiGene (NASDAQ: BGNE) was reported by Bernstein on March 27, 2024. The analyst firm set a price target for $161.00 expecting BGNE to rise to within 12 months (a possible 2.95% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for BeiGene (BGNE)?

A

The latest analyst rating for BeiGene (NASDAQ: BGNE) was provided by Bernstein, and BeiGene maintained their market perform rating.

Q

When was the last upgrade for BeiGene (BGNE)?

A

The last upgrade for BeiGene Ltd happened on October 13, 2022 when Guggenheim raised their price target to $205. Guggenheim previously had a neutral for BeiGene Ltd.

Q

When was the last downgrade for BeiGene (BGNE)?

A

The last downgrade for BeiGene Ltd happened on June 30, 2023 when Bernstein changed their price target from $335 to $196 for BeiGene Ltd.

Q

When is the next analyst rating going to be posted or updated for BeiGene (BGNE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BeiGene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BeiGene was filed on March 27, 2024 so you should expect the next rating to be made available sometime around March 27, 2025.

Q

Is the Analyst Rating BeiGene (BGNE) correct?

A

While ratings are subjective and will change, the latest BeiGene (BGNE) rating was a maintained with a price target of $196.00 to $161.00. The current price BeiGene (BGNE) is trading at is $156.39, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch